Tepotinib is a selective MET tyrosine kinase inhibitor that blocks signaling pathways involved in tumor cell growth and survival. It is used in the treatment of non-small cell lung cancer with MET exon 14 skipping alterations. By inhibiting MET, it disrupts oncogenic signaling and helps reduce tumor progression.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Tepotinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Tepotinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Tepotinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.